Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

NCT01916837 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT01916837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01916837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer
Lead sponsor
Jules Bordet Institute
Phase
Observational
Overall status
Completed
Start date
February 28, 2010
Completion date
December 31, 2010
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer